Literature DB >> 26042254

[Bisphosphonates as new anticancer agents?].

Jacques Robert1, William C Reinhold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26042254      PMCID： PMC7592604          DOI： 10.1016/j.bulcan.2015.02.010

Source DB:  PubMed          Journal:  Bull Cancer        ISSN： 0007-4551            Impact factor:   1.276


× No keyword cloud information.
  6 in total

1.  CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.

Authors:  William C Reinhold; Margot Sunshine; Hongfang Liu; Sudhir Varma; Kurt W Kohn; Joel Morris; James Doroshow; Yves Pommier
Journal:  Cancer Res       Date:  2012-07-15       Impact factor: 12.701

2.  Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer.

Authors:  Agnes Stachnik; Tony Yuen; Jameel Iqbal; Miriam Sgobba; Yogesh Gupta; Ping Lu; Graziana Colaianni; Yaoting Ji; Ling-Ling Zhu; Se-Min Kim; Jianhua Li; Peng Liu; Sudeh Izadmehr; Jaya Sangodkar; Thomas Scherer; Shiraz Mujtaba; Matthew Galsky; Jorge Gomez; Solomon Epstein; Christoph Buettner; Zhuan Bian; Alberta Zallone; Aneel K Aggarwal; Shozeb Haider; Maria I New; Li Sun; Goutham Narla; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

3.  Bisphosphonates inactivate human EGFRs to exert antitumor actions.

Authors:  Tony Yuen; Agnes Stachnik; Jameel Iqbal; Miriam Sgobba; Yogesh Gupta; Ping Lu; Graziana Colaianni; Yaoting Ji; Ling-Ling Zhu; Se-Min Kim; Jianhua Li; Peng Liu; Sudeh Izadmehr; Jaya Sangodkar; Jack Bailey; Yathin Latif; Shiraz Mujtaba; Solomon Epstein; Terry F Davies; Zhuan Bian; Alberta Zallone; Aneel K Aggarwal; Shozeb Haider; Maria I New; Li Sun; Goutham Narla; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

4.  Use of bisphosphonates and reduced risk of colorectal cancer.

Authors:  Gad Rennert; Mila Pinchev; Hedy S Rennert; Stephen B Gruber
Journal:  J Clin Oncol       Date:  2011-02-14       Impact factor: 44.544

Review 5.  Effects of bone-targeted agents on cancer progression and mortality.

Authors:  Robert Coleman; Michael Gnant; Gareth Morgan; Philippe Clezardin
Journal:  J Natl Cancer Inst       Date:  2012-07-02       Impact factor: 13.506

6.  The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Authors:  Jordi Barretina; Giordano Caponigro; Nicolas Stransky; Kavitha Venkatesan; Adam A Margolin; Sungjoon Kim; Christopher J Wilson; Joseph Lehár; Gregory V Kryukov; Dmitriy Sonkin; Anupama Reddy; Manway Liu; Lauren Murray; Michael F Berger; John E Monahan; Paula Morais; Jodi Meltzer; Adam Korejwa; Judit Jané-Valbuena; Felipa A Mapa; Joseph Thibault; Eva Bric-Furlong; Pichai Raman; Aaron Shipway; Ingo H Engels; Jill Cheng; Guoying K Yu; Jianjun Yu; Peter Aspesi; Melanie de Silva; Kalpana Jagtap; Michael D Jones; Li Wang; Charles Hatton; Emanuele Palescandolo; Supriya Gupta; Scott Mahan; Carrie Sougnez; Robert C Onofrio; Ted Liefeld; Laura MacConaill; Wendy Winckler; Michael Reich; Nanxin Li; Jill P Mesirov; Stacey B Gabriel; Gad Getz; Kristin Ardlie; Vivien Chan; Vic E Myer; Barbara L Weber; Jeff Porter; Markus Warmuth; Peter Finan; Jennifer L Harris; Matthew Meyerson; Todd R Golub; Michael P Morrissey; William R Sellers; Robert Schlegel; Levi A Garraway
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962
  6 in total
  1 in total

Review 1.  The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials.

Authors:  Xi Cheng; Jinrong Wei; Qi Ge; Danlei Xing; Xuefeng Zhou; Yunzhu Qian; Guoqin Jiang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.